Prevention of Migraine in Adolescents.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON21202

Enrollment

160

Registered

2006-09-18

Start date

2006-10-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group 1: Propanolol treatment + placebo relaxation treatment. Group 2: Placebo medical treatment + relaxation therapy.

Eligibility

Inclusion criteria

Inclusion criteria: Candidates are migraine patients, aged 13 to 18 years, living in Rotterdam.

Exclusion criteria

Exclusion criteria: Patients suffering from asthma, allergies and diabetes are excluded as well as patients who’ve been using propanolol and/or relaxation therapy as a treatment less then 6 months before the start of the trial.

Design outcomes

Primary

Measure	Time frame
Perceived effect and change of intensity, frequence and duration of migraine attacks.	—

Secondary

Measure	Time frame
Change in 'quality of life'- experience, number of schooldays missed and medical consumption.	—

Contacts

Public ContactD. Noordzij

Erasmus Medical Center Department of General Practice Westzeedijk 112-114

d.noordzij@erasmusmc.nl+31 (0)10 4632121

Outcome results